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Background: To evaluate the relevance of stress-induced decrease in left ventricular ejection fraction (LVEF) in
patients with type-2 diabetes.
Methods: A total of 684 diabetic patients with available rest and post-stress gated myocardial perfusion single-photon
emission computed tomography (MPS) data were enrolled. An automated algorithm was used to determine the
perfusion scores using a 17-segment model. LVEF drop was considered significant if the post-stress LVEF was ≥5%
below the rest value. Follow-up data were available in 587 patients that were followed for the occurrence of cardiac
death, nonfatal myocardial infarction, or unstable angina requiring revascularization.
Results: A post-stress LVEF drop ≥5% was observed in 167 (24%) patients. Patients with LVEF drop had higher summed
stress score (p < 0.05), summed difference score (p < 0.001), and rest LVEF (p < 0.001) compared to patients without.
Conversely, summed rest score, a measure of infarct size, was comparable between the two groups. At multivariable
analysis, summed difference score and rest LVEF were independent predictors (both p < 0.001) of post-stress LVEF drop.
Myocardial perfusion was abnormal in 106 (63%) patients with post-stress LVEF drop and in 296 (57%) of those without
(p = 0.16). The overall event-free survival was lower in patients with post-stress LVEF drop than in those without
(log rank χ2 7.7, p < 0.005). After adjusting for clinical data and MPS variables, the hazard ratio for cardiac events for
post-stress LVEF drop was 1.52 (p < 0.01).
Conclusions: In diabetic patients stress-induced ischemia is an independent predictor of post-stress LVEF drop;
however, a reduction in LVEF is detectable also in patients with normal perfusion. Finally, post-stress LVEF drop increases
the risk of subsequent cardiac events in diabetic patients.
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stunningBackground
Braunwald and Kloner [1] originally described myocar-
dial stunning as ‘delayed recovery of regional myocardial
contractile function after reperfusion despite the absence
of irreversible damage and despite restoration of normal
flow’. Stunning may be manifested on gated myocardial
perfusion single-photon emission computed tomography
(MPS) as wall motion abnormalities or as a post-stress* Correspondence: cuocolo@unina.it
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reproduction in any medium, provided the ordecrease in left ventricular ejection fraction (LVEF)
[2-7]. A drop in post-stress LVEF is an additional sign of
coronary artery disease (CAD) severity [8] and a prog-
nostic marker of cardiovascular events [9]. It is also
known that CAD is more prevalent and severe in pa-
tients with diabetes mellitus and the association between
diabetes and CAD is increasingly better understood
[10-12]. Emerging data support the utility of stress im-
aging in identifying diabetic patients with preclinical
CAD [13]. Diabetic patients have high incidence of heart
failure [14,15] and recognition of myocardial stunning
may be useful in these patients [16]. Despite an extensivetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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significance of a drop in post-stress LVEF in diabetic
patients. The aim of this study was to assess the rele-
vance of post-stress LVEF drop as evaluated by gated
MPS in a large cohort of diabetic patients.Table 1 Clinical characteristics and MPS findings







Age (years) 64 ± 10 63 ± 9 0.26
Male gender, n (%) 110 (66%) 351 (68%) 0.62Methods
Patients
The study population included 684 (461 men, age 63 ±
9 years) consecutive patients with type-2 diabetes and
available rest and stress gated MPS data, referred from
October 2005 to May 2007 for MPS for the detection of
myocardial ischemia. Among the overall patient popu-
lation, 74% had hypertension, 57% dyslipidemia, 34%
family history of CAD, and 39% history of myocardial
infarction. Patients have been excluded from study for:
1) recurrent chest pain unresponsive to anti-ischemic
medications; 2) recent acute coronary syndrome, stroke,
or transient ischemic attack (last 3 months); 3) un-
compensated congestive heart failure (New York Heart
Association class III or IV) or recent admission for con-
gestive heart failure (last 3 months); 4) prior myocardial
revascularization procedures; 5) an absolute contrain-
dication to dipyridamole in subjects with inability to
exercise; or 6) a concomitant noncardiac illness. The
ethics committee for the Biomedical Activities of the
University Federico II approved the study and all pa-
tients gave informed consent.Diabetes duration (months) 127 ± 111 117 ± 112 0.35
Oral treatment, n (%) 92 (55%) 268 (52%) 0.47
Insulin and oral, n (%) 51 (31%) 165 (32%) 0.74
Insulin, n (%) 24 (14%) 84 (16%) 0.56
Statin, n (%) 32 (19%) 91 (18%) 0.65
Hypertension, n (%) 128 (77%) 381 (74%) 0.44
Dyslipidemia, n (%) 98 (59%) 293 (57%) 0.64
Smoking, n (%) 67 (40%) 210 (41%) 0.81
Family history of CAD, n (%) 56 (34%) 178 (34%) 0.83
Prior myocardial infarction, n (%) 70 (42%) 198 (38%) 0.58
Exercise stress test, n (%) 88 (53%) 292 (56%) 0.39
Summed stress score 8.2 ± 8.2 6.7 ± 7.4 <0.05
Summed rest score 3.9 ± 5.6 4.1 ± 5.9 0.55
Summed difference score 4.3 ± 5.1 2.5 ± 3.1 <0.001
Rest LVEF (%) 60 ± 12 54 ± 14 <0.001
Post-stress LVEF (%) 52 ± 12 55 ± 14 <0.01
Rest EDV (ml) 95 ± 39 101 ± 46 0.13
Post-stress EDV (ml) 98 ± 41 102 ± 46 0.37
Rest ESV (ml) 42 ± 27 50 ± 38 <0.05
Post-stress ESV (ml) 51 ± 32 50 ± 39 0.80
CAD: coronary artery disease, LVEF: left ventricular ejection fraction,
EDV: end-diastolic volume, ESV: end-systolic volume.Gated MPS
All patients underwent same-day Tc-99 m sestamibi rest
and stress gated MPS by exercise or dipyridamole stress
test, according to the recommendations of the European
Association of Nuclear Medicine and European Society
of Cardiology [17]. An automated software program was
used to calculate LV volumes and EF and the scores in-
corporating both the extent and severity of perfusion de-
fects, using standardized segmentation of 17 myocardial
regions [18]. The difference between the post-stress and
rest LVEF was calculated. A significant LVEF reduction
was defined as a drop ≥5% between the post-stress and
rest LVEF [3,19]. Each myocardial segment was scored
from normal (score = 0) to absent perfusion (score = 4).
The summed stress score was obtained by adding the
scores of the 17 segments of the stress images. A similar
procedure was applied to the resting images to calculate
the summed rest score. The summed difference score
represents the difference between the stress and rest
scores and is taken to be an index of ischemic burden.
Patients were considered to have an abnormal MPS with
a summed stress score >3. Significant ischemia was de-
fined by a summed difference score >2, and classified as
mild/moderate (2 to 6) and severe (>6) [20].Coronary angiography
Of the 684 total patients included, 243 underwent coro-
nary angiography within 3 months of MPS. Coronary
angiography was performed using the standard Judkins
method. Experienced cardiologists visually interpreted
all coronary angiograms. Significant CAD was defined as
luminal coronary diameter stenosis of >50% in at least
one major coronary artery distribution [21].Follow-up
Follow-up data were obtained by the use of a question-
naire that was assessed by a phone call to all patients
and/or general practitioners or cardiologists and by re-
view of hospital records by individuals blinded to the pa-
tient’s test results. The end point was the occurrence of
cardiac death, nonfatal myocardial infarction, or unstable
angina requiring revascularization whichever occurred
first. The date of the last examination or consultation
was used to determine the length of follow-up.
Figure 1 Pie graphs showing the proportions of patients with
normal or abnormal myocardial perfusion according to the
presence or absence of a post-stress LVEF drop ≥5%.
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Continuous variables are described as mean ± standard
deviation and categorical data as percentages. Groups
were compared using t test, the Fisher’s exact test, or
χ2 test, as appropriate. A p value <0.05 was considered
statistically significant. Univariable associations with
post-stress LVEF drop ≥5% were determined by logistic
regression analysis. A multivariable model was con-
structed using a stepwise regression strategy (p < 0.05 for
model entry and p < 0.10 for model retention). To form
this model patients’ age, sex, diabetes duration, hyper-
tension, dyslipidemia, smoking, family history of CAD,
history of myocardial infarction, stress type, and MPS
variables were considered in the model selection process.
Survival curves were constructed using the Kaplan-
Meier method to account for censored survival times
and were compared with the log rank test. A multiva-
riable Cox proportional hazard regression model was
built to calculate the hazard ratio of cardiac events con-
sidering patients’ clinical data, stress type, MPS variables,
and post-stress LVEF drop ≥5%. The statistical software
used was SPSS Inc., Advanced Models 15.0 (Chicago,
Illinois).
Results
A total of 684 diabetic patients were included in the study.
The mean LVEF was 56 ± 14% at rest and 55 ± 14% post-
stress. Among the 684 diabetic patients included 167 hadTable 2 Univariable and multivariable predictors of post-stres
Univariable OR (95% CI)
Summed stress score 1.02 (1.00-1.04)
Summed difference score 1.11 (1.06-1.16)
Rest LVEF 1.03 (1.02-1.05)
OR: odds ratio, CI: confidence interval, LVEF: left ventricular ejection fraction.a post-stress reduction in LVEF ≥5%. The clinical charac-
teristics and MPS findings of diabetic patients with and
without post-stress LVEF drop are given in Table 1. As
shown, summed stress score, summed difference score,
and rest LVEF were significantly higher in patients with
post-stress LVEF drop compared to those without. Con-
versely, rest end-systolic volume was significantly lower in
patients with post-stress LVEF drop. Summed rest score, a
measure of infarct size, and the clinical variables were
comparable between the two groups. Myocardial perfu-
sion was abnormal in 106 (63%) patients with post-stress
LVEF drop and in 296 (57%) of those without (p = 0.16)
(Figure 1). Noteworthy, 37% of patients with post-stress
LVEF drop had normal myocardial perfusion.
Predictors of post-stress LVEF drop
Significant predictors of post-stress LVEF drop are re-
ported in Table 2. As shown, at univariable analysis among
all considered variables summed stress score, summed dif-
ference score, and LVEF at rest were significant predictors.
At multivariate analysis, the only independent predictors
were summed difference score and rest LVEF. The rela-
tion between the severity of ischemia and post-stress LVEF
drop is illustrated in Figure 2. As shown, severe ischemia
was more frequent in patients with post-stress LVEF drop
than in those without (p < 0.05). In the subgroup of 243
patients who underwent coronary angiography, the distri-
bution of the number of vessels with a significant coro-
nary stenosis was similar in patients with and without of
post-stress LVEF drop (Figure 3).
Post-stress LVEF drop and outcome
Follow-up data were available in 587 patients. The median
follow-up was 51.6 months (interquartile range, 41.4-
59.8). During follow-up, 181 end-point events occurred
(31% cumulative event rate). The events were cardiac
death in 41 patients, nonfatal myocardial infarction in 25
patients, and unstable angina requiring revascularization
in 133 patients. The Kaplan-Meier analysis showed that
the overall event-free survival was lower in patients with
post-stress LVEF drop than in those without (log rank
χ2 7.7, p < 0.005) (Figure 4). The hazard ratio (95% confi-
dence interval) for cardiac events for post-stress LVEF
drop was 1.52 (1.10-2.11, p < 0.01), after adjusting for
patients’ clinical data, stress type, and MPS variables.
When only patients with normal myocardial perfusions LVEF drop ≥5%
p-value Multivariable OR (95% CI) p-value
<0.05
<0.001 1.16 (1.10-1.22) <0.001
<0.001 1.05 (1.03-1.06) <0.01
Figure 3 Distribution of coronary artery disease (number of
diseased vessels) in relation to the presence or absence of a
post-stress LVEF drop ≥5%.
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patients with and without post-stress LVEF drop (log rank
χ2 2.5, p = 0.1).
Discussion
To our knowledge, this is the first study addressing the
relevance of post-stress LVEF drop in a large cohort of
patients with type-2 diabetes. The results show that
stress-induced ischemia is an independent predictor of a
post-stress LVEF drop, but LVEF fall is also detectable in
the absence of myocardial perfusion abnormalities. In
contrast, neither clinical variables nor infarct size were
associated with a post-stress LVEF drop.
It has been demonstrated that the post-stress LVEF
drop in patients with CAD is linked to regional perfu-
sion defects and predicts the presence of severe disease
[3,22]. In diabetic patients an abnormal LVEF response
to exercise has been documented by echocardiography
or radionuclide angiography also in the absence of CAD
[23-25]. Accumulating data showed that diabetes mel-
litus leads to cardiac functional and structural changes,
independent on hypertension, CAD, or any other known
cardiac disease, supporting the existence of a diabetic
cardiomyopathy [26].
In the present study performed in diabetic patients, al-
though severe ischemia was more frequent in patients
with post-stress LVEF drop, the distribution of the num-
ber of diseased vessels was similar in patients with and
without of post-stress LVEF drop. Noteworthy, post-
stress LVEF drop was present in a substantial number of
subjects (37%) without ischemia. Abnormality in the
contractile response during stress might explain this
finding, suggesting loss of contractile reserve [24]. An
important epidemiological evidence of the independent
effect of diabetes on LV systolic function is given by the
results of the Strong Heart Study [27]. Compared with
non-diabetics, patients with diabetes had greater LV
mass, and lower LV fractional shortening after adjustingFigure 2 Bar graphs illustrating the relation between the
magnitude of stress-induced ischemia and post-stress LVEF
drop ≥5%.for confounding covariables [27]. In addition, the pre-
sence of post-stress LVEF drop in diabetic patients with
normal perfusion may be also related to coronary vas-
cular dysfunction in the absence of significant coronary
artery stenosis [28-30]. This hypothesis is supported by
the observation that in the subgroup of patients who
underwent coronary angiography, the distribution of the
number of vessels with a significant coronary stenosis
was similar in patients with and without post-stress
LVEF drop.
As expected, summed difference score was an inde-
pendent predictor of post-stress LVEF drop. In parti-
cular, severe myocardial ischemia was found in 46% of
patients with and in 27% of those without post-stress
LVEF drop. Several studies reported that in patients with
suspected or known CAD stress-induced transient LV
dysfunction is associated with severe and extensive
ischemia [3-7,31,32]. However, these studies evaluated
post-stress LVEF drop in unselected patients population.
The finding of a higher LVEF at rest in patients with
post-stress LVEF drop is in agreement with previous
studies. In particular, Guenancia et al. [33] in patients
with recent myocardial infarction found high LVEFFigure 4 Event-free survival curves by Kaplan-Meier analysis
according to the presence or absence of a post-stress LVEF
drop ≥5%.
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LVEF drop. In our study, patients with post-stress LVEF
drop had a poorer outcome than those without. How-
ever, when only patients with normal myocardial
perfusion were considered, event-free survival was com-
parable in patients with and without post-stress drop in
LVEF, confirming the prognostic role of stress-induced
ischemia.
This study has some potential limitations. First, perfu-
sion patterns might influence the decrease of post-stress
LVEF [34,35]. However, it has been demonstrated that
gated MPS provides an accurate assessment of LVEF
even in the presence of large perfusion defects as
compared to equilibrium radionuclide angiography and
echocardiography [36]. Another limitation of this study
is the lack of hemoglobin A1c levels, which was not
available in all patients. In addition, coronary angio-
graphy was not performed in all patients.
Conclusions
In patients with diabetes stress-induced ischemia is an
independent predictor of post-stress LVEF drop; how-
ever, a fall in LVEF is detectable also in patients with
normal myocardial perfusion. These findings suggest
that a post-stress LVEF drop may be related to a specific
diabetic cardiomyopathy in the absence of myocardial
perfusion abnormalities. Finally, post-stress LVEF drop
increases the risk of subsequent cardiac events in dia-
betic patients.
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